Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
As the impacts of climate change are becoming increasingly severe worldwide, Keystone Symposia and...
On Earth Day, 2022, we launched our Climate Health ePanel series in collaboration with the... |
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to...
The convergence of new technology platforms (including induced pluripotent stem cells, CRISPR-Cas9...
This multidisciplinary conference will integrate emerging technologies and immunobiology to advance...
Precision genome engineering has completely revolutionized biological research and is making...
During last year's eSymposia series, each meeting featured a career roundtable with field leaders...
During last year's eSymposia series, editors from leading journals including Cell Press, Science,...
